ArticleHeliyon2023

Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients.

Chao Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.